Christopher H. Lieu

Also affiliated with University of Colorado Anschutz Medical Campus, University of Colorado Denver

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 29 papers. Top paper: “Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics data”.

Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics data

Nature Computational Science(2024)10.1038/s43588-024-00597-5

N/A

0.617DataRank · unranked

17 citations

Anna Capasso, S. Gail Eckhardt, Uma Giri, Alexander Somma, Todd M. Pitts +9 more

Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0065

N/A

0.488DataRank · unranked

16 citations

Adrian T.A. Dominguez, Shaikh M. Atif, Alberto Dinarello, Tania Azam, Kibrom M. Alula +11 more

Results from the safety lead-in for a phase II study of pembrolizumab in combination with binimetinib and bevacizumab in patients with refractory metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4031

N/A

0DataRank · unranked

8 citations

S. Lindsey Davis, Stephen Leong, Alexis D. Leal, Patrick J. Blatchford, Gurprataap Singh Sandhu +15 more

Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes

Frontiers in Immunology(2021)10.3389/fimmu.2021.607282

N/A

0DataRank · unranked

50 citations

Anna Capasso, Matthew S. Lewis, Stacey M. Bagby, Sarah J. Hartman, Jeremy Shulman +26 more

WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma

Frontiers in Oncology(2021)10.3389/fonc.2021.642328

N/A

0DataRank · unranked

30 citations

Stacey M. Bagby, Betelehem W. Yacob, Dennis M. Simmons, Morgan MacBeth, Christopher H. Lieu +8 more

Impact of Radiation Dose on Postoperative Complications in Esophageal and Gastroesophageal Junction Cancers

Frontiers in Oncology(2021)10.3389/fonc.2021.614640

N/A

0DataRank · unranked

9 citations

Megan Marsh, Martin D. McCarter, Robert A. Meguid, Narine Wandrey Bhardwaj, John D. Mitchell +17 more

Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion

Journal of Clinical Oncology(2022)10.1200/jco.21.02767

N/A

0DataRank · unranked

255 citations

Amber M. Johnson, Jeffrey Sklar, Neal I. Lindeman, Kathleen N. Moore, Shridar Ganesan +13 more

Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial

npj Precision Oncology(2022)10.1038/s41698-022-00256-w

N/A

0DataRank · unranked

43 citations

Zihan Wei, Ranee Mehra, Alice T. Shaw, Christopher H. Lieu, Patrick M. Forde +24 more

Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models

Frontiers in Oncology(2022)10.3389/fonc.2022.877635

N/A

0DataRank · unranked

16 citations

Alexis D. Leal, Juan A. Marín‐Jiménez, Sarah J. Hartman, Jeremy Shulman, Natalie M. Navarro +14 more

A phase II study of pembrolizumab, binimetinib, and bevacizumab in patients with microsatellite-stable, refractory, metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.118

N/A

0DataRank · unranked

8 citations

Patrick J. Blatchford, Robert W. Lentz, S. Lindsey Davis, Sunnie S. Kim, Alexis D. Leal +9 more

NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps212

N/A

0DataRank · unranked

7 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +8 more

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps3643

N/A

0DataRank · unranked

3 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +9 more

Chemotherapy delivery in early-onset colorectal cancer is impacted by urban versus rural settings in Colorado.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.019

N/A

0DataRank · unranked

1 citations

Junxiao Hu, Santi Das, Christopher H. Lieu, David Sheneman

Clinical research reactivation during the COVID-19 pandemic: An academic center process and lessons for the future

Journal of Translational Science(2022)10.15761/jts.1000468

N/A

0DataRank · unranked

0 citations

Alison Lakin, Laurie Blumberg-Romero, Thomas Campbell, John Heldens, Christopher H. Lieu +8 more

First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors

Cancers(2023)10.3390/cancers16010091

N/A

0DataRank · unranked

11 citations

Jodi Kagihara, Bradley R. Corr, S. Lindsey Davis, Christopher H. Lieu, Sunnie S. Kim +14 more

Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics data

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.20.524974

N/A

0DataRank · unranked

2 citations

Anna Capasso, S. Gail Eckhardt, Uma Giri, Alexander Somma, Todd M. Pitts +9 more

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3634

N/A

0DataRank · unranked

1 citations

Yu Guan, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Ibrahim Halil Sahin +10 more

NRG GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps260

N/A

0DataRank · unranked

0 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +10 more

Trial in progress: A phase II study (with safety run-in) of evorpacept (ALX148), cetuximab, and pembrolizumab in patients with refractory microsatellite-stable metastatic colorectal cancer (AGICC-ALX148 21CRC01).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps257

N/A

0DataRank · unranked

0 citations

Junxiao Hu, Patrick J. Blatchford, Todd M. Pitts, Alexis D. Leal, Sunnie S. Kim +7 more

A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0090

N/A

0DataRank · unranked

9 citations

Tyler J. Friedrich, Patrick J. Blatchford, Kimberly R. Jordan, Todd M. Pitts, Hannah R. Robinson +13 more

Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL)

PLoS ONE(2024)10.1371/journal.pone.0298808

N/A

0DataRank · unranked

8 citations

Betelehem W. Yacob, Monica E. Brown, Brandon R. Goldstein, John J. Arcaroli, Stacey M. Bagby +11 more

Body compassion in the context of cancer: A novel exploration among colorectal cancer survivors

Supportive Care in Cancer(2024)10.1007/s00520-024-08996-0

N/A

0DataRank · unranked

5 citations

Aimee J. Christie, Jennifer Altman, Andrew Nicklawsky, James W. Carson, Christopher H. Lieu +3 more

Results of a phase 2 study of evorpacept (E, ALX148), cetuximab (C), and pembrolizumab (P) in patients with refractory microsatellite stable metastatic colorectal cancer (MSS CRC).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.3530

N/A

0DataRank · unranked

1 citations

Patrick J. Blatchford, Junxiao Hu, Todd M. Pitts, Adrie Van Bokhoven, Hannah R. Robinson +13 more

1950P Squamous cell carcinoma of unknown primary (SCCUP): A genomic landscape study

Annals of Oncology(2024)10.1016/j.annonc.2024.08.2035

N/A

0DataRank · unranked

0 citations

Stephanie Lakritz, D.C. Pavlick, S. Lindsey Davis, Christopher H. Lieu, Corinna Eule +15 more

Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center

Frontiers in Oncology(2025)10.3389/fonc.2025.1546500

N/A

0DataRank · unranked

0 citations

Sama L. Kareem, Bradley R. Corr, Christopher H. Lieu, Breelyn A. Wilky, S. Lindsey Davis +9 more

A First-In-Human Dose-Escalation Phase I Study of Basroparib, a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid Tumors

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0502

N/A

0DataRank · unranked

0 citations

Heinz‐Josef Lenz, Al B. Benson, Xue Meng, Uk-Il Kim, Song Hyun Kim +3 more

Early-Onset Esophageal Adenocarcinoma Presents With Advanced-Stage Disease But Has Improved Survival Compared With Older Individuals

Gastroenterology(2020)10.1053/j.gastro.2020.08.002

N/A

0DataRank · unranked

48 citations

Samuel Han, Frank I. Scott, Caitlin C. Murphy, Patrick Hosokawa, Sachin Wani +10 more

Beyond mindfulness: the importance of body compassion in colorectal cancer distress

Frontiers in Psychology(2025)10.3389/fpsyg.2025.1618389

N/A

0DataRank · unranked

0 citations

Aimee J. Christie, Andrew Nicklawsky, Jennifer Altman, James W. Carson, Christopher H. Lieu +3 more

Early-Onset Appendiceal Cancer Survival by Race or Ethnicity in the United States

Gastroenterology(2020)10.1053/j.gastro.2020.06.011

N/A

0DataRank · unranked

19 citations

Kay Washington, Safia N. Salaria, Christopher H. Lieu, Kamran Idrees, Cathy Eng +1 more